1. Nasr M R , El-Zammar O . Comparison of pHH3, Ki-67, and Survivin Immunoreactivity in Benign and Malignant Melanocytic Lesions[J]. The American Journal of Dermatopathology, 2008, 30(2):117-122.
2. Hightower E, Cabanillas M E, Fuller G N, et al. Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas[J]. Pituitary, 2012, 15(4):556-561.
3. 中华医学会.《临床技术操作规范·病理学分册》.人民军医出版社,2004.